Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study.
Bersanelli M, Verzoni E, Cortellini A, Giusti R, Calvetti L, Ermacora P, Di Napoli M, Catino A, Guadalupi V, Guaitoli G, Scotti V, Mazzoni F, Veccia A, Guglielmini PF, Perrone F, Maruzzo M, Rossi E, Casadei C, Montesarchio V, Grossi F, Rizzo M, Travagliato Liboria MG, Mencoboni M, Zustovich F, Fratino L, Accettura C, Cinieri S, Camerini A, Sorarù M, Zucali PA, Ricciardi S, Russo A, Negrini G, Banzi MC, Lacidogna G, Fornarini G, Laera L, Mucciarini C, Santoni M, Mosillo C, Bonetti A, Longo L, Sartori D, Baldini E, Guida M, Iannopollo M, Bordonaro R, Morelli MF, Tagliaferri P, Spada M, Ceribelli A, Silva RR, Nolè F, Beretta G, Giovanis P, Santini D, Luzi Fedeli S, Nanni O, Maiello E, Labianca R, Pinto C, Clemente A, Tognetto M, De Giorgi U, Pignata S, Di Maio M, Buti S, Giannarelli D; FICOG group (Federation of Italian Cooperative Oncology Groups). Bersanelli M, et al. Among authors: nanni o. EClinicalMedicine. 2023 Jun 29;61:102044. doi: 10.1016/j.eclinm.2023.102044. eCollection 2023 Jul. EClinicalMedicine. 2023. PMID: 37434748 Free PMC article.
Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial.
Grassi E, Zingaretti C, Petracci E, Corbelli J, Papiani G, Banchelli I, Valli I, Frassineti GL, Passardi A, Di Bartolomeo M, Pietrantonio F, Gelsomino F, Carandina I, Banzi M, Martella L, Bonetti AV, Boccaccino A, Molinari C, Marisi G, Ugolini G, Nanni O, Tamberi S. Grassi E, et al. Among authors: nanni o. ESMO Open. 2023 Oct;8(5):101824. doi: 10.1016/j.esmoop.2023.101824. Epub 2023 Sep 27. ESMO Open. 2023. PMID: 37774508 Free PMC article. Clinical Trial.
A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL).
Cafaro A, Foca F, Nanni O, Chiumente M, Coppola M, Baldo P, Orzetti S, Enrico F, Ladisa V, Lerose R, Nardulli P, Maiolino P, Gradellini F, Gasbarro AR, Carrucciu G, Provasi R, Cappelletto PC, Pasqualini A, Vecchia S, Veraldi M, De Francesco AE, Crinò L, Delmonte A, Masini C. Cafaro A, et al. Among authors: nanni o. Front Oncol. 2024 Mar 27;14:1351995. doi: 10.3389/fonc.2024.1351995. eCollection 2024. Front Oncol. 2024. PMID: 38601759 Free PMC article.
Radiotherapy at the End of Life: From Retrospective Analysis to Strategies to Improve Outcomes.
Rossi R, Cravero P, Pallotti MC, Valenti V, Massa I, Foca F, Nanni O, Pieri M, Romeo A, Tontini L, Donati CM, Morganti AG, Maltoni M. Rossi R, et al. Among authors: nanni o. J Pain Symptom Manage. 2024 Jun;67(6):e927-e929. doi: 10.1016/j.jpainsymman.2024.03.001. Epub 2024 Mar 10. J Pain Symptom Manage. 2024. PMID: 38467347 No abstract available.
TransFAIR study: a European multicentre experimental comparison of EHR2EDC technology to the usual manual method for eCRF data collection.
Ammour N, Griffon N, Djadi-Prat J, Chatellier G, Lewi M, Todorovic M, Gómez de la Cámara A, García Morales MT, Testoni S, Nanni O, Schindler C, Sundgren M, Garvey A, Victor T, Cariou M, Daniel C. Ammour N, et al. Among authors: nanni o. BMJ Health Care Inform. 2023 Jun;30(1):e100602. doi: 10.1136/bmjhci-2022-100602. BMJ Health Care Inform. 2023. PMID: 37316249 Free PMC article.
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET.
Gennari A, Brain E, De Censi A, Nanni O, Wuerstlein R, Frassoldati A, Cortes J, Rossi V, Palleschi M, Alberini JL, Matteucci F, Piccardo A, Sacchetti G, Ilhan H, D'Avanzo F, Ruffilli B, Nardin S, Monti M, Puntoni M, Fontana V, Boni L, Harbeck N; ET-FES Collaborative Group. Gennari A, et al. Among authors: nanni o. Ann Oncol. 2024 Feb 28:S0923-7534(24)00057-7. doi: 10.1016/j.annonc.2024.02.007. Online ahead of print. Ann Oncol. 2024. PMID: 38423389
CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/HER2-Negative Breast Cancer: Results and Correlative Biomarker Analyses of the KENDO Randomized Phase II Trial.
Schettini F, Palleschi M, Mannozzi F, Brasó-Maristany F, Cecconetto L, Galván P, Mariotti M, Ferrari A, Scarpi E, Miserocchi A, Nanni O, Sanfeliu E, Prat A, Rocca A, De Giorgi U. Schettini F, et al. Among authors: nanni o. Oncologist. 2024 May 3;29(5):e622-e634. doi: 10.1093/oncolo/oyad337. Oncologist. 2024. PMID: 38175669 Free PMC article. Clinical Trial.
Predicting Functional Recovery and Quality of Life in Older Patients Undergoing Colorectal Cancer Surgery: Real-World Data From the International GOSAFE Study.
Montroni I, Ugolini G, Saur NM, Rostoft S, Spinelli A, Van Leeuwen BL, De Liguori Carino N, Ghignone F, Jaklitsch MT, Kenig J, Garutti A, Zingaretti C, Foca F, Vertogen B, Nanni O, Wexner SD, Audisio RA; SIOG Surgical Task Force/ESSO GOSAFE Study Group. Montroni I, et al. Among authors: nanni o. J Clin Oncol. 2023 Dec 1;41(34):5247-5262. doi: 10.1200/JCO.22.02195. Epub 2023 Jun 30. J Clin Oncol. 2023. PMID: 37390383
Identification of palliative care needs and prognostic factors of survival in tailoring appropriate interventions in advanced oncological, renal and pulmonary diseases: a prospective observational protocol.
Valenti V, Rossi R, Scarpi E, Dall'Agata M, Bassi I, Cravero P, La Manna G, Magnoni G, Marchello M, Mosconi G, Nanni O, Nava S, Pallotti MC, Rapposelli IG, Ricci M, Scrivo A, Spazzoli A, Valenti D, Zambianchi L, Caraceni A, Maltoni M. Valenti V, et al. Among authors: nanni o. BMJ Open. 2023 May 30;13(5):e065971. doi: 10.1136/bmjopen-2022-065971. BMJ Open. 2023. PMID: 37253494 Free PMC article.
206 results